301015 Qingdao Baheal Medical INC.
- 26.20
- +2.58+10.92%
About Qingdao Baheal Medical INC. Company
The company was founded in 2005 as a pharmaceutical industrialization platform that supports innovation at the source. Its core business focuses on product development, manufacturing and commercial operation of medical innovation achievements, and effectively optimizes medical scenarios through scientific and technological innovation. The company's main business is to provide overall commercial solutions for pharmaceutical product manufacturers, covering the three sectors of brand operation, wholesale distribution and retail. Main products or businesses: Operates brands such as Diqao series, Hale series, Takeda series, Roche series, Keonis, Esnona, Neutschuma, Atricure, Fuzhenghua, Zisheng, etc.; distributes pharmaceuticals, Chinese medicine tablets, medical devices, diagnostic reagents, medical consumables, etc.; sells pharmaceuticals, medical devices, health food, cosmetics, etc. Corporate honors: Top 50 service enterprises in Shandong in 2021, the first batch of Chinese OTC brand clusters, 2021 Pharmaceutical Industry “13th Five-Year” Enterprise Management Award - Outstanding Growth Enterprise, certified by Euromonitor as “No. 1 in the domestic imported calcium supplement market for eight consecutive years”, and won honors such as the “Nursery Network” Orange Product of the Year Top 10 Pharmaceutical and Nutritional Products for Popular Mom Products of the Year.
Company Profile
Company Executives
- Name
- Position
- Salary
- gang fu
- Chairman, Directors, General Manager, Nomination Committee Members, Strategy Committee Convener
- 3.59M
- qing song
- Directors, Strategy Committee Members, Remuneration and Assessment Committee Members, Audit Committee Member
- --
- yuan zhang
- Directors, Deputy General Manager
- 2.61M
- xiaowei zhu
- Directors, Deputy General Manager, Strategy Committee Members
- 2.46M
- guoqiang wang
- Directors, Board Secretary, Deputy General Manager, Chief Financial Officer
- 2.54M
- haishen chen
- Directors
- --
- mingzhong fu
- Independent Directors, Audit Committee Members, Strategy Committee Members, Nomination Committee Convener
- 150.00K
- xianjing hao
- Independent Directors, Audit Committee Convener, Remuneration and Assessment Committee Members
- 150.00K
- yindi lu
- Independent Directors, Remuneration and Assessment Committee Convener, Nomination Committee Members
- 150.00K
- nina liu
- Securities Affairs Representative
- --
- jun mou
- Chairman of the Supervisory Board, Auditors
- --
- xuebiao li
- Auditors
- 1.30M
- tingwei wang
- Deputy General Manager
- 2.61M
- biquan wang
- Deputy General Manager
- 2.50M
- nan du
- Employee Supervisors
- 1.18M
Analysis
Price Target
No Data
No Data